From left (standing) are: Kate Carroll, Devesh Vashishtha, and Kathryn Tringale; (seated) Charlie Park, Alex Bryant, Arvin Wali, and Jeremy Udkoff. Not pictured are Nadine Patton and Lilianna Yuen.
June 26, 2018
Congratulations to the nine ACTRI-supported students who received their medical degrees and Master’s of Advanced Studies (MAS) in Clinical Research from UC San Diego School of Medicine on June 3. The students were supported by ACTRI through the TL1 long-term training program. The program includes a mentored clinical research experience for a 12-month period that is coupled with enrollment in the MAS in Clinical Research program.
"We are very proud of our new graduates and know they are going on to make their mark in diverse fields of medicine as physician-investigators," said Carolyn Kelly, MD, director of the ACTRI TL1 Program and Associate Dean for Admissions and Student Affairs at UC San Diego School of Medicine.
Upon graduation, the new graduates were headed to their residency destinations:
- Alex Bryant, Radiation Oncology, University of Michigan
- Kate Carroll, Neurosurgery, University of Washington
- Charlie Park, Diagnostic Radiology, Emory University School of Medicine
- Nadine Patton, Child Neurology, University of Texas, Houston
- Kathryn Tringale, Radiation Oncology, Memorial Sloan Kettering Cancer Center
- Jeremy Udkoff, Dermatology, University of Pittsburgh Medical Center
- Devesh Vashishtha, Family Medicine, Swedish Medical Center Cherry Hill, Seattle, WA
- Arvin Wali, Neurosurgery, UC San Diego
- Lilianna Yuen, Psychiatry, UCSF Fresno
About UC San Diego Altman Clinical and Translational Research Institute:
UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members.